Curacaine
Product Images NDC 51350-012

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Curacaine (NDC 51350-012). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Transdermal Corp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Curacaine_label_primary_lidocaine HCl (Curacaine Label Primary Lidocaine HCl)

CURACAINE Rapid Acting Topical Analgesic in a 1 fl oz (30 ml) bottle carton by Transdermal Corp. The label highlights the product as scientifically advanced for itching and pain relief. The active ingredient is Lidocaine HCl 4%, and it is intended for topical analgesic use.*

FDA Label Image

Curacaine_rev 061915_r3 (Curacaine Rev 061915 R3)

Top and sides of the CURACAINE packaging label by Transdermal Corp feature blue background with bold yellow and white text. It highlights maximum strength lidocaine 4% in a rapid-acting topical analgesic cream form, designed for relieving itching and pain from insect bites, sunburn, minor cuts, burns, and skin irritations. The label mentions 'Advanced Itching + Pain Relief Formula' and showcases the net weight of 1 fl oz (30 ml).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.